Adverse cutaneous reactions to drugs.

Drug eruptions are probably the most frequent of all manifestations of drug sensitivity. They occur in about 2% of treatment courses and are commoner in women, the elderly and in patients with the acquired immunodeficiency syndrome (AIDS), especially from sulphonamides such as in co-trimoxazole1. Drugs most often incriminated are listed in Table 1. The prevalence of a history of penicillin allergy has been estimated as up to 10%, and reactions to sulphonamides may affect 5% of those treated. Potentially fatal conditions such as Stevens–Johnson syndrome and toxic epidermal necrolysis are fortunately rare (0.5–1.8 cases per million per year)2. Adverse drug reactions may reflect immunological drug allergy or, more usually, non-immunological mechanisms. Idiosyncratic reactions are independent of dose, unrelated to the pharmacological action of the drug and may have a genetic basis3. This article lists the commonest clinical patterns of drug eruptions (excluding contact dermatitis) and reviews their management.

[1]  J. Litt,et al.  Drug Eruption Reference Manual , 2002 .

[2]  J. Roujeau Treatment of Severe Drug Eruptions , 1999, The Journal of dermatology.

[3]  H. Merk,et al.  Metabolites and allergic drug reactions. , 1998, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[4]  R. Sontheimer,et al.  DIDMOHS: a proposed consensus nomenclature for the drug-induced delayed multiorgan hypersensitivity syndrome. , 1998, Archives of dermatology.

[5]  G. Faure,et al.  The use of skin testing in the investigation of cutaneous adverse drug reactions , 1998, The British journal of dermatology.

[6]  N. Levell,et al.  Systemic corticosteroids in the phenytoin hypersensitivity syndrome , 1996, The British journal of dermatology.

[7]  L. Hughes-Davies,et al.  Severe adverse cutaneous reactions to drugs. , 1995, The New England journal of medicine.

[8]  R. Stern,et al.  Severe adverse cutaneous reactions to drugs. , 1994, The New England journal of medicine.

[9]  J. Roujeau,et al.  Drug rashes. What are the targets of cell-mediated cytotoxicity? , 1994, Archives of Dermatology.

[10]  M. Spence,et al.  Clinical experience with penicillin skin testing in a large inner-city STD clinic. , 1993, JAMA.

[11]  J. Roujeau,et al.  Drug-induced toxic epidermal necrolysis (Lyell syndrome) in patients infected with the human immunodeficiency virus. , 1992, Journal of the American Academy of Dermatology.

[12]  H. Hintner,et al.  Adverse Drug Reactions and the Skin , 1992 .

[13]  S. Jick,et al.  The incidence of erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis. A population-based study with particular reference to reactions caused by drugs among outpatients. , 1990, Archives of dermatology.

[14]  M. Lepper,et al.  Drug reactions. , 1958, Disease-a-month : DM.